U.S., Jan. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07361705) titled 'Zorifertinib With Osimertinib for NSCLC With Meningeal Progression' on Dec. 04, 2025.
Brief Summary: This is a clinical trial that aims to test Zorifertinib when used together with a known drug, Osimertinib. The goal is to learn if this combination is safe and works for people with advanced Non-Small Cell Lung Cancer (NSCLC) whose cancer has spread to the membranes surrounding the brain and spinal cord (a condition called leptomeningeal metastases) after being treated with Osimertinib.
Study Start Date: Jan. 31
Study Type: INTERVENTIONAL
Condition:
Patients With Advanced Non-small Cell Lung Cancer With Meningeal Progression Afte...